{"id":74438,"date":"2025-12-30T07:15:11","date_gmt":"2025-12-30T07:15:11","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/74438\/"},"modified":"2025-12-30T07:15:11","modified_gmt":"2025-12-30T07:15:11","slug":"kohus-tunnistas-hepsor-as-i-sidusettevotte-hepsor-p113-ou","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/74438\/","title":{"rendered":"Kohus tunnistas Hepsor AS-i sidusettev\u00f5tte Hepsor P113 O\u00dc"},"content":{"rendered":"<p>Hepsor \u2013 B\u00f6rsiteade<\/p>\n<p>Kohus tunnistas Hepsor AS-i sidusettev\u00f5tte Hepsor P113 O\u00dc kahjun\u00f5uet eks\u00fc\u00fcrniku vastu summas 6\u00a0090\u00a0257,27 EUR<\/p>\n<p>2023-09-05 avaldatud b\u00f6rsiteates teatas Hepsor AS, et tema 45%-lise osalusega sidusettev\u00f5te Hepsor P113 O\u00dc \u00fctles 4. septembril 2023 \u00fcles \u00fc\u00fcrilepingu Novel Clinic Assets O\u00dc-ga. Hepsor P113 O\u00dc-le kuulub ca 4 000 m2\u00a0\u00fc\u00fcritava pinnaga \u00e4rihoone Tallinnas, aadressil P\u00e4rnu mnt 113, millest l\u00f5petatud \u00fc\u00fcrileping oli s\u00f5lmitud 3 575 m2-ile.<\/p>\n<p>\u00dc\u00fcrileping l\u00f5petati \u00fc\u00fcrniku poolse \u00fc\u00fcrilepingu tingimuste olulise ja pideva rikkumise t\u00f5ttu.<\/p>\n<p>Novel Clinic Assets O\u00dc esitas 9. novembril 2023 Harju Maakohtule Hepsor P113 O\u00dc suhtes hagiavalduse, milles vaidlustas \u00fc\u00fcrilepingu l\u00f5petamise ja n\u00f5udis selle taastamist, kahju h\u00fcvitamist ning ruumidesse j\u00e4\u00e4nud vara v\u00e4ljaandmist (b\u00f6rsiteade 2023-12-15)<\/p>\n<p>Hepsor P113 O\u00dc vaidles hagile vastu ja esitas menetluses vastuhagi, milles n\u00f5udis eks\u00fc\u00fcrnikult \u00fc\u00fcrilepingu ennet\u00e4htegse l\u00f5petamisega p\u00f5hjustatud kahju h\u00fcvitamist.<\/p>\n<p>04.12.2024 kuulutas maakohus v\u00e4lja Novel Clinic Assets O\u00dc pankroti, mis j\u00f5ustus l\u00f5plikult 11.02.2025.<\/p>\n<p>Hepsor P113 O\u00dc esitas oma kahjun\u00f5ude Novel Clinic Assets O\u00dc pankrotimenetluses.<\/p>\n<p>19.12.2025 kinnitas Harju Maakohus Novel Clinic Assets O\u00dc v\u00f5lausaldajate nimekirja, milles asus seisukohale, et Hepsor P113 O\u00dc-l oli \u00f5igus \u00fc\u00fcrileping Novel Clinic Assets O\u00dc-ga \u00fcles \u00f6elda.<\/p>\n<p>Kohus tunnistas Hepsor P113 O\u00dc kahjun\u00f5udeid Novel Clinic Assets O\u00dc suhtes summas 6\u00a0090\u00a0257,27 EUR 1. j\u00e4rgu n\u00f5udena. Sellest 2 947\u00a0092,88 eurot on tingimuslik ja s\u00f5ltub sellest, kas k\u00f5nealune osa kahjust tulevikus v\u00e4heneb.<\/p>\n<p>Kohus leidis, et kogu Hepsor P113 O\u00dc n\u00f5ue on tagatud \u00fc\u00fcrileandja seadusj\u00e4rgse pandi\u00f5igusega Novel Clinic Assets O\u00dc \u00fc\u00fcritud ruumidesse j\u00e4\u00e4nud varale.<\/p>\n<p>Kohtulahend on hetkel veel j\u00f5ustumata.<\/p>\n<p>Martti Krass<\/p>\n<p>Juhatuse liige<\/p>\n<p>Telefon: +372 5692 4919<\/p>\n<p>e-post: martti@hepsor.ee<\/p>\n<p>Hepsor AS (www.hepsor.ee) on elu- ja \u00e4rikondliku kinnisvara arendaja. Kontsern tegutseb Eestis, L\u00e4tis ja Kanadas. Neljateistk\u00fcmne tegutsemisaasta jooksul oleme loonud 2 003 kodu ja ligi 44 787 m2 \u00e4ripindasid. Hepsor on esimese arendajana Balti riikides rakendanud mitmeid uuenduslikke insener-tehnilisi lahendusi, mis muudavad ettev\u00f5tte rajatavad hooned energias\u00e4\u00e4stlikumaks ja seel\u00e4bi keskkonnas\u00f5bralikumaks. Ettev\u00f5tte portfellis on kokku 25 arendusprojekti kogupindalaga 178 200 m2. Lisaks tegutseb kontsern viies Kanada projektis, kus p\u00f5hitegevuseks on maa detailplaneeringute koostamine ning seel\u00e4bi suurema ehitus\u00f5iguse saavutamine.<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=c-X4HmV090ZPWWNvvlj5MgUfKTOBrMRxtmpuW5vpzB2CKAXTgTj85P3AUW0JApdGkzynRixxLGC4Csd9HEIcKZF9TeOTo5plRxnmHw0-9ZtGUaJNa73rCM73bR4C_w_Xl8pQFPY2IthIaQsPgrdnGkPTWYYvd_RFDFltG_Y5IoyXWSuJb38mDB47cE79Vo6s6MlEcwOwqdRZiqm54t9uvg==\" title=\"Hepsor AS bo\u0308rsiteade 2025-12-12_est\" rel=\"nofollow noopener\">Hepsor AS bo\u0308rsiteade 2025-12-12_est<\/a>\n      <\/li>\n<\/ul>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.europesays.com\/ee\/wp-content\/uploads\/2025\/12\/HEPSOR-AS.png\" referrerpolicy=\"no-referrer-when-downgrade\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"Hepsor \u2013 B\u00f6rsiteade Kohus tunnistas Hepsor AS-i sidusettev\u00f5tte Hepsor P113 O\u00dc kahjun\u00f5uet eks\u00fc\u00fcrniku vastu summas 6\u00a0090\u00a0257,27 EUR 2023-09-05&hellip;\n","protected":false},"author":2,"featured_media":14259,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[26,27,37,33,35,34,36,31,32,21,9285,28,29,19,25,9284,23,24,22,20,30],"class_list":{"0":"post-74438","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-eesti","8":"tag-breaking-news","9":"tag-breakingnews","10":"tag-ee","11":"tag-eesti","12":"tag-eesti-keel","13":"tag-estonia","14":"tag-estonian","15":"tag-featured-news","16":"tag-featurednews","17":"tag-headlines","18":"tag-hepsor-as","19":"tag-latest-news","20":"tag-latestnews","21":"tag-news","22":"tag-populaarseimad-lood","23":"tag-tallinn-stock-exchangehpr1t","24":"tag-top-stories","25":"tag-topstories","26":"tag-uldised-uudised","27":"tag-uudised","28":"tag-viimased-uudised"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/115807290869675957","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/74438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=74438"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/74438\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/14259"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=74438"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=74438"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=74438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}